Effects Of Sulbutiamine On Diabetic Polyneuropathy: An Open Randomised Controlled Study In Type 2 Diabetics

Effect None
Trial Design Cohort
Trial Length n/a
Number of Subjects 30
Gender Both Genders
Age Range 45-64
Notes for this study:
6 weeks of 400mg Sulbutiamine was unable to influence symptoms and signs of diabetic neuropathy although it did significantly benefit electrophysical readings; no influence was noted in blood glucose or HbA1c